Chagas' disease and Human African Trypanosomiasis are parasitic diseases that remain major health problems, mainly among the poorest and the most marginalized communities from Latin America and Africa. The scarcity of effective chemotherapy, due to the low investment in the research and development (R&D) of new drugs, together with a high incidence of side effects, and the emergence of drug resistance phenomena emphasize the urgent need for new prophylactic and therapeutic agents. Over the ages, humans have employed natural products to treat a wide spectrum of diseases. Recently, the pharmaceutical industry has focused on plant research and a large body of evidence has been collected to demonstrate the immense potential of medicinal plants as a source of bioactive compounds and lead molecules. In the field of parasitic diseases, drug development from plants has been successful for the sesquiterpene lactone (STL) artemisinin, which is employed as an antimalarial agent. STLs are a large group of naturally occurring terpenoids derived from plants that mostly belong to the Asteraceae family which exhibit a variety of skeletal arrangements and are the largest and most diverse category of natural products with an αmethylene-λ-lactone motif. STLs display a broad spectrum of biological activities such as antitumor, cytotoxic, antibacterial, anthelmintic, uterus contracting, antimalarial, neurotoxic, antiprotozoal and allergic (contact dermatitis) activities. In this context, the purpose of the present review is to provide an overview of the trypanocidal activity reported for STLs against Trypanosoma cruzi and T. brucei rhodesiense over the period 1993-2015.
Chagas' disease and Human African Trypanosomiasis (HAT) are known as "neglected tropical diseases" due to the lack of effective drug treatments and the scarcity of research devoted to their study. Therefore, these diseases are not properly considered by the pharmaceutical market. Chagas' disease, also known as American Trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. Parasite circulation is high in the 21 Latin American endemic countries where transmission to humans mostly occurs through the feces of triatomine bugs, known as 'kissing bugs' [1] .
About six to seven million people are estimated to be infected worldwide, mostly in Latin America. However, in the past decades, cases have also been detected in the United States of America, Canada, many European and some Western Pacific countries. This phenomenon is mainly due to the existence of migratory currents between Latin America and the rest of the world. Rarely, does infection occur through blood transfusions, vertical transmission (from infected mother to child) or organ donation [1, 2] . With an annual incidence of 56,000 cases, it is estimated that there are 100 million people at risk, and an average 12,000 deaths per year occur due to this infection [2] . In Argentina, there are 1.5 million infected people, 7.3 million exposed to the parasite and more than 300,000 affected by chagasic cardiopathies. Chagas' disease presents three different clinical stages: acute, indeterminate and chronic. In the acute phase, most patients have mild, self-limited symptoms such as fever and nausea that may not call the patient´s attention. A minority of patients will experience a non-specific febrile illness including fever, chills, vomiting, diarrhea, rash, meningeal irritation, conjunctivitis and lymphadenopathy [3] [4] [5] . People with chronic T. cruzi infection, but without signs or symptoms of Chagas' disease, are considered to have the "indeterminate" form of infection. This stage is characterized by the presence of specific serum antibodies in the absence of clinical manifestations [4, 5] . Over a period of decades, 15-30% of patients in the indeterminate stage will develop a chronic complication thereby progressing to the determinate chronic stage of Chagas' disease. The most common manifestations of the latter stage are cardiac and gastrointestinal. Lesions affect the heart and the nervous system (central and peripheral, affecting concomitantly the digestive system) [5] . Only two drugs exist for the treatment of this disease: benznidazole and nifurtimox. These drugs are the only available (and approved) ones and used to treat the majority of the acute cases. Despite having been developed in the 1960s and 1970s, these are the only drugs with proven efficacy against T. cruzi [3, 4, 6] . Benznidazole and nifurtimox are effective against the acute phase of infection, and while there is increasing evidence of their efficacy against the chronic phase, the use of these drugs has been limited due to lack of guidelines and policies supporting its implementation. The use of these compounds has drawbacks that include the requirement of long treatment periods (60-90 days), the occurrence of dosedependent toxicity, and a high dropout rate of patients due to side effects. There is currently no approved treatment for the chronic form of the disease with target organ involvement [7] .
HAT occurs in two stages: stage 1 -the hemolymphatic phase that includes non-specific symptoms like headaches, malaise and fever and stage 2 -the neurologic phase, which occurs when the parasite invades the CNS, leading to serious sleep cycle disruptions, paralysis and progressive mental deterioration. In the absence of treatment, the disease progresses to cause death.
Available treatments for stage 1 are pentamidine and suramine; however, these drugs have limitations because they require injections and are ineffective for stage 2 (they do not cross the blood-brain barrier). Combination of nifurtimox and eflornithine is a simplified therapy option for stage 2 T. b. gambiense sleeping sickness. Melarsoprol is still the only drug available for stage 2 T. b. rhodesiense, but it is a toxic arsenic derivative that causes fatal reactive encephalopathy in 3-10% of cases. Eflornithine is an alternative to melarsoprol treatment for late stage T. b. gambiense infection, but is ineffective against T. b. rhodesiense. Furthermore, the treatment requires trained health staff and a long hospital stay [9] .
The scarcity of effective chemotherapy for Chagas' disease and HAT, together with a high incidence of side effects, and the emerging resistance to available drugs emphasize the urgent need for new prophylactic and therapeutic agents. In this sense, natural products play an important role. Over the ages, humans have relied on nature to cater for their basic needs including medicines for the treatment of a wide spectrum of diseases. Recently, the pharmaceutical industry has focused on plant research and a large body of evidence has been collected to demonstrate the immense potential of medicinal plants. Many drugs on the market have been derived from natural products, allowing these products to have an overwhelming influence on the success of the pharmaceutical industry [10] . Several reviews regarding the antiprotozoal activity of plant metabolites, isolated from higher plants, have been published over the last years [9, [11] [12] [13] [14] [15] [16] . Within the different classes of bioactive compounds, most frequently isolated and identified, terpenoids, flavonoids, alkaloids and lignanes seem to be the most promising ones as lead molecules with trypanocidal activity. Among the terpenoid subclasses, triterpenes and sesquiterpene lactones (STLs) have proved to have potential as leads for the development of new therapeutic agents [17] . STLs are a large group of secondary plant metabolites from which more than 5000 structures are known, mostly from the Asteraceae (formerly known as Compositae) family which can thus be considered the major "pool" of STLs structural diversity [18, 19] . STLs are common constituents of most genera of the Asteraceae family. The percentage of lactones obtained can vary quantitatively in a given species: from 0.001 to 5% on a dry weight basis. Lactones are rarely found in stems and roots [20] . Most Asteraceae STLs have been isolated from the leaves or the flowering heads, in which they constitute up to 5% of dry weight [21, 22] . STLs are 15-carbon (15-C) compounds consisting of three isoprene (5-C) units and a lactone group (cyclic ester) [23] . These compounds are colorless, bitter, relatively stable, lypophilic constituents, which are biogenetically derived from trans, trans farnesyl pyrophosphate following an initial cyclisation and subsequent oxidative modifications. The major types of lactones are classified primarily on the basis of their carbocyclic skeletons as: germacranolides, guaianolides, elemanolides, seco-guaianolides, pseudoguaianolides, eudesmanolides, eremophilanolides, cadinanolides and xanthanolides. The suffix "olide" refers to the lactone group [19] .
Structural modifications of the basic terpene skeleton involve the incorporation of an epoxide ring, hydroxyl groups (generally esterified), and/or a 5-carbon acid, such as tiglic or angelic acid. Some STLs also contain covalently bound halogen atoms [20] . Numerous species of Asteraceae are used in traditional medicine, especially for the treatment of inflammation, and STLs are described as their primary active constituents. These compounds have a wide variety of structures and, accordingly, they also display a broad spectrum of biological activities, including antitumor, cytotoxic, antibacterial, anthelminthic, uterus contracting, antimalarial, neurotoxic and allergic (contact dermatitis) activities [19] . One of the most relevant examples is artemisinin that was isolated during the '70s from the Chinese traditional medicinal plant Artemisia annua. Since its discovery, artemisinin and its derivatives have become the first line treatment for malaria. However, not only did artemisinin (and its derivatives) demonstrate its effectiveness against Plasmodium falciparum, the causitive agent of malaria, but also it displayed a cytotoxic effect against a variety of cancer cell lines [24] . Most biological activities of STLs have been related to the presence of electrophilic structural elements that can form covalent bonds with functional biological macromolecules resulting in their deactivation. In this regard, α,β-unsaturated carbonyl groups, as well as epoxide and free aldehyde groups, have to be considered reactive partial structures. The alkylation of free cysteine residues in enzymes and other functional proteins by STLs has, in many instances, been held responsible for their bioactivity and there is a clear correlation between the presence of such residues in proteins and their susceptibility to inactivation by STLs [18] .
The purpose of the current review is to provide a comprehensive summary of the literature on STLs as potential trypanocidal drugs against T. cruzi and T. b. rhodesiense over the period 1993-2015.
Sesquiterpene lactones with trypanocidal activity against T. cruzi and T. b. rhodesiense
Schmidt et al. [25] reported the anti-trypanosomal activity of helenanolide and eudesmanolide type STLs, isolated from Arnica and Inula species (Asteraceae). All tested compounds (helenalin, mexicanin I, 11α,13-dihydrohelenalin acetate, chamissonolide, ivalin and isoalantolactone) were found to be active against T. b. rhodesiense and T. cruzi trypomastigotes, the former being more sensitive to these compounds. Helenalin (Figure 1 ) was the most active STL, with 50% inhibitory concentration (IC 50 ) values of 0.05 and 0.69 µM against T. b. rhodesiense and T. cruzi, respectively. These authors have found that saturation of the cyclopentenone or the α-methylene-β-lactone moieties resulted in a dramatic decrease of activity. They have also noted that STLs containing bifunctional alkylants had selective toxicity towards African trypanosomes, while those with monofunctional alkylants did not. The trypanocidal activity of STLs is shown in Table 1 .
Helenalin and mexicanin were also tested against T. cruzi epimastigotes. Both compounds were cytotoxic to the parasites, with IC 50 values of 1.9 and 3.8 µM, respectively. Nuclear disorganization and cytoplasmic vacuolization were observed by transmission electron microscopy (TEM), which may account for an apoptotic effect of the compounds on the parasites [26] .
The effect of the STL dehydroleucodine, isolated from Artemisia douglassiana (Asteraceae), on cultured T. cruzi epimastigotes has been investigated by Brengio et al. [27] . The presence of the compound in the culture medium inhibited replication of the parasites at concentrations between 5 and 50 µg/mL. After treatment with the compound, morphological and ultrastructural changes were also observed, such as thinner cells when compared with controls, pycnotic nuclei and a decrease in the number of ribosomes in the treated parasites.
Later, Lozano et al. [28] tested the effect of dehydroleucodine, helenalin and mexicanin on T. cruzi amastigotes (Y-strain). At concentrations of 1.5-3.8 μM and after 48 h of treatment, the number of amastigotes inside the cells was lower than in the controls. The compounds also reduced the presence of trypomastigotes in the extracellular medium. Helenalin was the most potent STL.
As reported by Jimenez et al. [29] , dehydroleucodine and helenalin induce programmed cell death in the epimastigote and trypomastigote forms of T. cruzi. In contrast, benznidazole and nifurtimox do not induce programmed cell death, indicating a different mechanism of action than the conventional drugs. A combination of dehydroleucodine with either benznidazole or nifurtimox induced a more pronounced decrease of parasite viability.
From the CH 2 Cl 2 extract of Inula montbretiana (Asteraceae), six STLs, all esters of 9β-hydroxyparthenolide, were isolated. The diastereomeric mixture of 9β-(3′,4′-epoxy-3′-methylpentanoyloxy)parthenolide and 9β-(3′-oxo-2′-methylbutanoyloxy)-parthenolide was the most active component in in vitro assays against T. b. rhodesiense, with an IC 50 value of 0.69 μM and was less cytotoxic against rat skeletal myoblasts (L6 cell line), with a selectivity index (SI) of about 9. Against T. cruzi trypomastigotes, the mixture was less active, with an IC 50 value of 14.4 μM [30] .
Bioassay-guided fractionation of the light petroleum extract of Munnozia maronii (Asteraceae) led to the isolation and identification of dehydrozaluzanin C, a new natural guaianolide STL. This compound has been tested for in vitro trypanocidal activity against 15 strains of epimastigote forms of T. cruzi. After 24 h, dehydrozaluzanin C showed an inhibitory activity on all strains, with IC 90 values between 5 and 50 µg/mL [31] .
Neurolaena lobata (Asteraceae) is a traditional medicinal plant from Guatemala, frequently used as a remedy for malaria, stomach pain, skin diseases, diabetes and anemia. The STL neurolenin B and the mixture of the isomeric neurolenin C and D (3:2) have been isolated from the ethanolic extract of this plant. The pure compound and the mixture inhibited T. cruzi growth in the same range as the reference drugs nifurtimox and benznidazole. Neurolenin B was found to be more active against epimastigotes (IC 90 = 6.3 µg/mL) and trypomastigotes (IC 90 = 4.9 µg/mL) than the mixture of neurolenin C and D (IC 90 = 11.7 and 6.1 µg/mL against the epimastigote and trypomastigote forms, respectively) [32] .
Lychnophora pohlii (Asteraceae) has STL type furanoheliangolides, that are taxonomic markers of the subtribe Lychnophorine of Vernoniae. From the CH 2 Cl 2 extract of this plant, Grael et al. [33] have isolated, by bioassay-guided fractionation, four STLs (lychnopholide, centratherin, goyazensolide and 15desoxygoyazensolide). The compounds were tested against T. cruzi trypomastigotes. Goyazensolide showed the highest activity against the trypomastigote forms of T. cruzi with an IC 50 value of 56.9 µM. The other STLs showed weak activity. Apparently, the methacrylate ester and the hydroxyl group at position C-15, making the molecule more polar, have an influence on activity causing an upgrade in the biological action of these compounds.
The natural guaianolide STL cynaropicrin was identified from the herb Centaurea salmantica (Asteraceae) as a potent in vitro inhibitor of T. b. rhodesiense (IC 50 = 0.3 μM) and T. b. gambiense (IC 50 = 0.2 μM), compared with T. cruzi (4.4 μM). Cytotoxicities against rat myoblasts (L6 cells), human colon adenocarcinoma cells (HT-29), and murine peritoneal macrophages have been measured to find SI values of 7.8, 62, and 9.5 for each cell type, respectively. The in vivo effect of cynaropicrin has also been evaluated in the T. b. rhodesiense STIB 900 acute mouse model, which induced a 92% reduction of parasitemia three days after the end of the treatment period, as compared with untreated controls. The deacyl derivative of cynaropicrin was 31 times less active against T. b. rhodesiense and 3.4 times less toxic against L6 cells, indicating the necessity of the 2-(hydroxymethyl)2-propenoic acid side chain for the trypanocidal activity [34] .
In a subsequent study, the effect of cynaropicrin on enzymes of the T(SH) 2 redox metabolism, including trypanothione reductase, trypanothione synthetase, glutathione-S-transferase, and ornithine decarboxylase has been evaluated by Zimmermann et al. [35] . After exposure to the compound, the cellular glutathione and T(SH) 2 pools were entirely depleted due to the formation of cynaropicrinthiol adducts, which led to parasite death. Cynaropicrin also inhibited ornithine decarboxylase but it did not show significant interactions with other enzymes involved in the T(SH) 2 redox metabolism.
Chemical derivatization and a structure activity relationship (SAR) study of cynaropicrin derivatives against T. b. rhodesiense have been carried out by Usuki et al. [36] . All the compounds were tested for in vitro activity against the parasites and for cytotoxicity to mammalian cells. The authors concluded that an acyl side chain at OH-8 is essential for the activity and the 2-hydroxylmethyl-2propenoic acid side chain affects the selectivity. The derivatization of the two hydroxyl groups (OH-3 and OH-19) does not affect significantly the trypanocidal activity.
Sato et al. [37] have reported the synthesis of cynaropicrin-d 4 , a cynaropicrin deuterated derivative that could be employed as an internal standard for liquid chromatography-mass spectrometry (LC-MS) analysis in the pharmacokinetics study of cynaropicrin.
Mokoka et al. [38] have reported the in vitro trypanocidal activity of sixty plants growing in South Africa. The most active species against T. b. rhodesiense were Schkuhria pinnata and Vernonia mespilifolia, both from the Asteraceae family. HPLC-based activity In the course of a bioactivity-guided isolation study, two STLs with significant trypanocidal activity have been isolated from the organic extract of Ambrosia tenuifolia (Asteraceae). These compounds were identified as psilostachyin A and peruvin. Both compounds showed a marked in vitro trypanocidal activity against T. cruzi epimastigotes with IC 50 values of less than 2 μg/ml. Psilostachyin A also exerted a significant in vitro activity against the trypomastigote forms of T. cruzi (IC 50 = 0.76 μg/mL). Interestingly, in an in vivo assay, 100% of psilostachyin treated mice infected with T. cruzi survived, presenting lower parasitemia values than control mice. The cytotoxic effect of the STLs on T lymphocytes has also been evaluated. Although the SI values of both compounds were high for T. cruzi epimastigotes, psilostachyin A was more selective against trypomastigotes (SI, 33.8) [39] .
The effect has also been evaluated of psilostachyin A on the growth and viability of T. cruzi epimastigotes (Tulahuen strain). The effect on parasite growth was irreversible at concentrations higher than 1.0 μg/mL and the addition of glutathione only partially blocked the effect of the compound. Ultrastructural alterations to the parasites, such as important mitochondrial swelling and deformity of the kinetoplast were observed at a concentration of 0.5 μg/mL [40] .
The same authors have reported the anti-T. cruzi activity of the STL psilostachyin C, isolated from A. scabra (Asteraceae). The compound exerted in vitro trypanocidal activity against T. cruzi epimastigotes, trypomastigotes and amastigotes, with IC 50 values of 0.6, 3.5 and 0.9 µg/mL, respectively, and displayed less cytotoxicity against mammalian cells, with a 50% cytotoxic concentration (CC 50 ) of 87.5 g/mL. Further studies on this compound showed that its anti-parasite activity is not reversible at concentrations higher than 1.0 μM. When the STL was evaluated for its in vivo activity, a significant reduction in the number of circulating parasites was found in T. cruzi-infected mice treated with psilostachyin C for 5 days, compared with untreated mice (7.4±1.2×10 5 parasites/mL vs. 12.8±2.0×10 5 parasites/mL) at the peak of parasitemia. Moreover, this compound induced ultrastructural alterations (as assessed by TEM) featuring vacuolization and a structural appearance resembling multivesicular bodies [41] .
Later, Sülsen et al. [42] reported the isolation of the STLs cumanin from A. elatior (Asteraceae) and cordilin and psilostachyin A from A. scabra (Asteraceae). Cumanin was active against T. cruzi epimastigotes with IC 50 values of 12 μM (RA strain) and 4 μM (K98 strain). IC 50 values obtained for cordilin were 26 μM (RA strain) and 44 μM (K98 strain). Against bloodstream trypomastigotes, IC 50 values of 180 and 90 μM were obtained for cumanin and cordilin, respectively. Cumanin and psilostachyin A were also active against the amastigote forms of T. cruzi, with IC 50 values of 8 μM and 21 μM, respectively. The authors found that cumanin and psilostachyin A exhibited an additive trypanocidal effect when these two drugs were tested together. In an in vivo model, cumanin was more active than benznidazole, producing an 8-fold reduction in parasitemia levels during the acute phase of the infection, compared with the control group, and a reduction in mortality with 66% of surviving animals, in comparison with 100% mortality obtained in the control group.
The trypanocidal activity of cynaropicrin, isolated from Cynara scolymus (Asteraceae), together with psilostachyin A, from Ambrosia tenuifolia (Asteraceae), has also been evaluated against T. cruzi (Y strain) trypomastigotes and amastigotes. Cynaropicrin was the most active STL against the bloodstream trypomastigotes with an EC 50 value of 1.0 μg/mL vs an EC 50 1574 Natural Product Communications Vol. 11 (10) 2016
Muschietti & Ulloa structures suggestive of parasite autophagy. Although both compounds present in vitro trypanocidal effects, the compounds failed to control in vivo infection. With respect to the in vitro and in vivo trypanocidal activities of psilostachyin A, the data obtained do not agree with previous studies [39] . This discrepancy may be due to the different parasite strains used (RA and Y strains), and different in vivo models employed such as treatment periods, doses and route administration [43] .
The STL lychnopholide was isolated from the crude extracts of Lychnophora trichocarpha (Asteraceae) and tested in vitro against T. cruzi trypomastigotes (IC 50 = 150 μg/mL). The IC 100 value could not be determined due to its low solubility under the test conditions [44] . The poor aqueous solubility, high lipophilicity and chemical instability in alkaline media of lychnopholide hamper therapeutic application of the drug. To solve this problem, Branquinho et al. [45] have evaluated the in vivo activity of lychnopholide loaded in polymeric nanocapsules (Lyc-NC) during the acute phase of infection in mice experimentally infected with T. cruzi. Results obtained demonstrated that Lyc-NC showed therapeutic effects such as the reduction of parasitemia, improvement of animal survival and higher cure rates in mice infected with T. cruzi Y strain, which is partially resistant to benznidazole and nifurtimox.
Oxide derivatives of eremantholide C, another STL from L. trichocarpha, have been evaluated against T. cruzi (Y and CL strains). All the derivatives were inactive against the Y strain. Only 3'-hydroxyeremantholide C and 1'-carbomethoxyeremantholide C displayed 100% activity on the CL strain [46] .
Anthecotulide, 4-hydroxyanthecotulide and 4-acetoxyanthecotulide, three linear STLs, have been isolated from Anthemis auriculata (Asteraceae) and tested for their in vitro trypanocidal activity against the trypomastigotes forms of T. b. rhodesiense and T. cruzi. All these compounds showed trypanocidal activity against T. b. rhodesiense, showing less potency against T. cruzi. 4-Hydroxyanthecotulide was the most active one towards T. b. rhodesiense with an IC 50 value of 0.56 µg/mL. However, the three metabolites rendered low SI values, indicating that they were toxic to mammalian cells. The STLs were also tested against recombinant T. b. rhodesiense trypanothione reductase, but all three compounds failed to inactivate the enzyme, indicating that the trypanocidal activity must be due to another mechanism of action. 4-Hydroxyanthecotulide was the most active STL against the trypomastigote form of T. cruzi, (IC 50 = 5.72 µg/mL), followed by anthecotulide (IC 50 = 18.05 µg/mL); while 4-acetoxyanthecotulide was inactive at the highest concentration tested [47] .
Anthecularin, another STL obtained from A. auriculata, had previously been identified by the same authors. The compound showed trypanocidal activity against T. b. rhodesiense (IC 50 =10.1 µg/mL) [48] .
Bioassay-guided fractionation of the methanolic extract of Laurus nobilis (Lauraceae) allowed the isolation of the guaianolides, dehydrocostus lactone and zaluzanin D. The minimum lethal concentrations (MLCs) of these compounds against T. cruzi epimastigotes were 6.3 and 2.5 µM, respectively [49] .
The STL 8β-hydroxyzaluzanin D has been isolated from Mikania hoehnei (Asteraceae) and tested for its activity against the trypomastigote forms of T. cruzi (Y strain). The compound displayed low activity, inducing percentages of parasite growth inhibition of 56.6 and 81.0% at 250 and 500 µg/mL, respectively [50] .
Michelia alba (Magnoliaceae) is a tree native to Indonesia, traditionally used for the treatment of fever, syphilis, gonorrhea and malaria. The STLs costunolide, dihydrocostunolide, parthenolide, dihydroparthenolide, 11,13-dehydrolanuginolide and santamarine have been isolated from the ethyl acetate extract of this plant and tested for their activity against T. cruzi epimastigotes. The most active compounds were parthenolide, dihydroparthenolide and 11,13-dehydrolanuginolide with minimum lethal concentrations (MLCs) of 0.04, 0.78 and 0.16 µM respectively; while costunolide (MLC = 7.0 µM), dihydrocostunolide (MLC = 27 µM) and santamarine (MLC = 25 µM) were less active. The most active compounds bear an epoxide functional group together with an α, βunsaturated -lactone or a -lactone moiety, indicating that the epoxide plays an important role in the trypanocidal activity [51] .
Later, the trypanocidal activity of parthenolide, in this case isolated form Tanacetum parthenium (Asteraceae), was investigated by Izumi et al. [52] . The STL showed an IC 50 value of 0.5 µg/mL against T. cruzi epimastigotes and a CC 50 value in LLMCK2 cells of 3.2 µg/mL, with a SI= 6.4. By scanning electron microscopy (SEM), morphological alterations such as cellular distortion, swelling, flattening, a decrease in cell length and cell shape were observed in epimastigotes treated with parthenolide. Alterations in the nucleus, reservosomes, mitochondrion and vacuoles were observed by TEM analysis.
From the same species, Cogo et al. [53] have isolated the STL 11,13-dehydrocompressanolide. This was proved to be effective against T. cruzi epimastigotes, trypomastigotes and amastigotes, with IC 50 values of 18.1, 5.7 and 66.6 µM, respectively, without being toxic to LLCMK2 cells (CC 50 = 93.5 µM). A synergistic effect against the epimastigote form and a marginal additive effect against the trypomastigote form were observed after the combination of benznidazole and the STL. Ultrastructural alterations such as membranes that enveloped reservosomes and the nucleus and the formation of myelin-like structures were detected in epimastigotes treated with the compound. T. cruzi-treated trypomastigotes showed changes in cell shape, similar to those observed with parthenolide. By SEM, treated epimastigotes showed an increase in cell length and a decrease in cell width.
HPLC-based activity profiling of the ethyl acetate extract of Saussurea costus (Asteraceae) roots allowed the identification of the STLs arbusculin B, α-cyclocostunolide, costunolide and dehydrocostuslactone, which belong to the eudesmanolide, germacranolide and guaianolide classes. The isolated compounds inhibited the growth of T. b. rhodesiense. In parallel, a comparative study with some related STLs such as parthenolide (commercial source), zaluzanin D (from Laurus nobilis) [49] and eupatoriopicrin (from Eupatorium cannabium) was carried out. The three germacranolides parthenolide, eupatoriopicrin and costunolide were the most active STLs with IC 50 values of 0.8, 1.2 and 1.3 µM, respectively. These results suggest that the presence of the epoxide at position 3 or the esterified hydroxyl side chain at position 7 did not induce a significant effect on the antitrypanosomal activity [54] . [55] .
The STLs enhydrin, uvedalin and polymatin B have been isolated from the organic extract of Smallanthus sonchifolius (Asteraceae) by a bioassay-guided fractionation technique. The three compounds showed activity against T. cruzi epimastigotes and trypomastigotes. Against the intracellular forms, enhydrin, uvedalin and polymatin B were able to inhibit amastigote replication, with IC 50 values of 5.17, 3.34 and 9.02 µM respectively. The cytotoxicity of each compound, evaluated in Vero cells, indicated some selective toxicity against T. cruzi amastigotes with SI values between 9-16.3 [56] .
The pseudoguaianolides damsin and confertin, isolated from Ambrosia peruviana (Asteraceae), have been tested for trypanocidal activity against T. cruzi trypomastigotes. Although these STLs are structural isomers, damsin was inactive (IC 50 > 200 μM), compared with confertin (IC 50 = 13.2 μM) [57] .
The STL identified as deoxyelephantopin was isolated by bioassayguided fractionation from the methanolic extract of Elephantopus scaber (Asteraceae). This compound exhibited significant trypanocidal activity against T. b. rhodesiense (strain STIB 900), with an IC 50 value of 0.024 µg/mL and a CC 50 value (L-cell) of 1.41 µg/mL (SI = 64.5) [58] .
Nobilin is a natural heliangolide type STL isolated from the flowers of Anthemis nobilis (Asteraceae). The transannular cyclization of nobilin in acidic conditions has been carried out by De Mieri et al. [59] . The in vitro anti-trypanosomal activity of the obtained derivatives against T. b. rhodesiense bloodstream forms was evaluated and compared with nobilin (IC 50 = 3.19 μM). The tricyclic derivative identified as (3aR,4S,6S,6aR,8S,10aR)-8-hydroxy-6,9dimethyl-3-methylene-2-oxo-3,3a,4,5,6,6a,7, 8-octahydro-2Hnaphtho [8a,1-b]furan-4-yl (Z)-2-methylbut-2-enoate was the most potent compound, with an IC 50 value of 0.46 μM.
From the CHCl 2 extract of Eupatorium perfoliatum (Asteraceae), four structurally similar guaianolides, one dimeric guaianolide, and two germacranolide were isolated by Maas et al. [60] . In general, the compounds displayed weak trypanocidal activity against T. b. rhodesiense and T. cruzi. The most active STL against the former was the dimeric guaianolide: 5S,6R,7R,8R,11R,14S-14-hydroxy-2oxo-14(4S,5S,6R,7R,8R,11R-8-tigloyloxyguaia-1(10),2-diene 6,12,2,14-diolid-4-yl)-8-tigloyloxyguaia-1(10),3-diene-6,12-olide (IC 50 = 6.2 µM), but it also displayed low selectivity (SI=2.6).
With respect to SAR studies, a very interesting evaluation of 40 STLs against T. b. rhodesiense and T. cruzi has been performed by Schmidt et al. [61] . The cytotoxic activity against L6 rat skeletal myoblast cells has also been evaluated. Among the tested parasites, T. b. rhodesiense was found to be the most sensitive to the STLs. Helenalin and some of its esters esters such as 6-O-acetylhelenalin (IC 50 = 0.06 µM, Figure 1 ) showed high activity against this parasite with IC 50 values of 0.05-0.1 μM together with xanthanolide 8-epixanthatin-1,5-epoxide (IC 50 =0.33 μM), isolated from Xanthium brasilicum (Asteraceae). Correlation of the bioactivity showed that the antiprotozoal activity is, in most cases, significantly correlated with cytotoxicity against L6 cells, with the exception of eight STLs which displayed significantly higher levels of antiparasitic activity, especially against T. b. rhodesiense. A quantitative structure-activity-relationship (QSAR) analysis has demonstrated that the antiparasitic activity against T. brucei and cytotoxicity depend, to a large extent, on the same structural elements and molecular properties. The difference in the biological activity can be explained in terms of subtle variations in the relative influences of various molecular descriptors.
Later, Trossini et al. [62] , and as a continuation of the previous work [61] , have applied the hologram quantitative structure-activity relationship (HQSAR) approach to relate the activity of 40 STLs against T. brucei, T. cruzi, L. donovani and P. falciparum and also with their cytotoxicity. The objective was to construct comparable models and employ the molecular fragment information to analyze the structural basis for the bioactivity and cytotoxicity. The constructed HQSAR models showed good internal consistency and external predictivity, which was suitable to predict the activity of untested STLs.
In the same year, Schmidt et al. [63] performed an extended QSAR analysis of 69 STLs for activity against T. b. rhodesiense. The obtained QSAR model was used to predict the activity of a virtual library of 1750 STLs. In this sense, furanoheliangolide-type STLs have been predicted to have the most potent in vitro trypanocidal activity. This prediction was experimentally confirmed with the STLs: goyazensolide (IC 50 = 0.07 μM), 4,5-dihydro-2´,3´-epoxy-15deoxygoyazensolide (IC 50 = 0.20μM), budlein A (IC 50 = 0.07μM) and 4,15-isoatriplicolide tiglate (IC 50 = 0.015μM).
Zimmermann et al. [64] have tested a set of 34 natural STLs, semisynthetic STLs and amino-STLs for in vitro activity against T. b. rhodesiense and for cytotoxicity against mammalian cancer cells, in order to carry out a SAR study. The authors found that antitrypanosomal selectivity is conferred by the 2-(hydroxymethyl) acrylate and 3,4-dihydroxy-2-methylenebutylate side chains and by the presence of cyclopentenone rings. Semi-synthetic STL amines with morpholino-and dimethylamino-groups were more active than the native STLs.
In another study, the anti-T.cruzi and cytotoxic activities of a series of 15 natural STLs (all isolated from the Asteraceae family) and a QSAR study was undertaken by Fabian et al. [65] . A significant trypanocidal activity against T. cruzi epimastigotes and high SI values were found for the STLs enhydrin (IC 50 = 0.84 μM), estafietin (IC 50 = 0.24μM) and eupahakonenin B (IC 50 = 0.78 μM). A model using 3D molecular descriptors allowed the set-up of a high correlation of the observed activity and the atomic spatial arrangement of the STLs closely related to steric parameters.
Concluding remarks
The lack of effective chemotherapy for Chagas' disease and HAT emphasizes the need for new therapeutic agents. In this sense, natural product metabolites play an important role. In particular, STLs are featured mainly by their high chemical diversity and biochemical specificity that make them promising as lead structures from which new drugs can be further developed.
The majority of the STLs have been isolated from the Asteraceae family with the exception of costunolide, 11,13dehydrolanuginolide, parthenolide and santamarine, which have been isolated from the Magnoliaceae familiy, and zaluzanin D and dehydrocostus lactone (Lauraceae).
These classes of compounds seem to be more active against T. b. rhodesiense. Furanoheliangolide-type STLs (such as goyazensolide,
Muschietti & Ulloa 4,5-dihydro-2´,3´-epoxy-15-deoxygoyazensolide, budlein A, and 4,15-isoatriplicolide tiglate), helenalin and its esters, 8-epixanthatin 1β,5β-epoxide, cynaropicrin, deoxyelephantopin, mexicanin I and nobilin trycyclic derivative were the most active STLs, with IC 50 values below 0.5 μM. Estafietin, eupahakonenin B, 6-O-acetylhelenalin, helenalin and lychnopholide were reported to be active against T. cruzi epi-or trypomastigotes. According to data summarized in Table 1 , only approximately 22% of the reported STLs showed IC 50 values against T. cruzi that were lower than 1.0 µM, whereas this proportion rises to almost 52% in the case of T. b. rhodesiense. The most active STLs against T. cruzi belong mostly to the pseudoguaianolide type, followed by germacranolides and guaianolides. Among STLs with activity against T. b. rhodesiense, both germacranolides and pseudoguaianolides have proved to be active.
The majority of the STLs have been screened only in in vitro assays using trypomastigote and epimastigote forms of T. cruzi. In vitro studies employing intracellular forms of the parasite should also be performed. Many reported compounds are highly active and selective in in vitro assays, therefore, in vivo assays should be carried out. Only the trypanocidal activity of cynaropicrin, psilostachyin A, psilostachyin C, lychnopholide and cumanin have been evaluated by in vivo bioassays. This is particularly important since many medicinal plant projects never go beyond the in vitro analysis. Another important issue for the development of new trypanocidal drugs involves the identification of specific targets within key metabolic pathways. Various potential protein targets have been identified for chemotherapy to treat Chagas' disease and HAT. However, literature data on the interaction of STLs with different targets are scarce. In the reviewed period, only the effect of cynaropicrin on enzymes of the T(SH) 2 redox metabolism of T. b. rhodesiense and the effect of anthecotulide, 4-hydroxyanthecotulide and 4-acetoxyanthecotulide, against recombinant T. b. rhodesiense trypanothione reductase enzyme have been evaluated. Most of the activities of STLs are explained by the formation of covalent bonds between the unsaturated -lactone moiety with biological nucleophiles, especially cysteine protein residues. Structure-activity relationship (SAR) studies on antiprotozoal activity of STLs have demonstrated that the activity is mainly related to the presence of reactive α,β-unsaturated carbonyl groups, and an exocyclic methylene group at the -lactone. The high cytotoxicity of STLs has usually been associated with high cytotoxicity in mammalian cells. There are some examples of this class of compounds that are considerably more toxic to parasites, showing good selectivity indices such as the STLs of the furonoheliangolide and guaianolide types. In contrast, many STLs present promising trypanocidal activities, but high cytotoxicity to mammalian cells. The latter drawback justifies the performance of further studies such as the synthesis of analogues by chemical modifications, aiming at improving their selectivity.
The results of our literature search have demonstrated that STLs are a group of lead molecules with significant trypanocidal activity. Nevertheless, further investigation is needed to bring about more conclusive results and learn more about their mechanism of action and their bioavailability. Investigations of these subjects, mainly carried out by the academic area and partnership cooperation, will encourage the pharmaceutical industry to develop new trypanocidal drugs.
